DFX Intelligence
Data Factory
Reading the graph
Reading the graph
Venture Capital
San Francisco, CA
The Column Group (TCG) is a venture ecosystem dedicated to fueling scientific innovation in the life sciences industry.
Data as of (this record's last observation) from federal regulator filings, firm and issuer disclosures. Page built and rebuilt at most every 15 minutes.
| Fund | Vintage | Lifecycle | Form D sold | GAV | LPs |
|---|---|---|---|---|---|
| Column Group-Neuro II, LP | 2024 | Early deployment | $100M | n/a | 0 |
| The Column Group V LP | 2022 | Active deployment | $600M | $592M | 0 |
| The Column Group Opportunity III LP | 2022 | Active deployment | $600M | $652M | 0 |
| The Column Group Spv I, LP | 2022 | Active deployment | $10.5M | $10.4M | 0 |
| The Column Group - Neuro, LP | 2021 | Mature | $100M | $99.9M | 0 |
| The Column Group Iva LP | 2020 | Mature | $0 | $32.5M | 0 |
| The Column Group IV, LP | 2020 | Mature | $0 | $1.1B | 0 |
| Ponoi Capital II, LP | 2019 | Mature | $0 | $385M | 0 |
| Ponoi Capital LP | 2017 | Harvest | $0 | $434M | 0 |
| The Column Group Iiia, LP | 2016 | Harvest | $271M | $180M | 0 |
| The Column Group III, LP | 2016 | Harvest | $240M | $160M | 0 |
| The Column Group II, LP | 2010 | Harvest | $65.5M | $232M | 0 |
| The Column Group, LP | n/a | Unknown | n/a | $377M | 0 |
| Column Group Opportunity IV, LP | n/a | Fundraising | $0 | n/a | 0 |
| Column Group VI, LP | n/a | Fundraising | $0 | n/a | 0 |
| Company | State | Stage | Round size | Partner | Attribution | Observed |
|---|---|---|---|---|---|---|
| Surrozen | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Tortugas Neuroscience | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Carmot Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Peloton Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Seragon Pharmaceuticals | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Constellation Pharmaceuticals | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| SyntheX,Inc. | CA | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Judo Bio Inc. | Ma | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Aragon Pharmaceuticals | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Neurona Therapeutics, Inc | CA | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Flexus Biosciences | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Oric Pharmaceuticals, Inc. | CA | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Tenaya Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Ngm Bio | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| A2 Biotherapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Nura Bio | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Plexium, Inc. | CA | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Synthekine | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| RAPT Therapeutics, Inc. | CA | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Kallyope | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Hexagon Bio | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Tr1x Bio | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Lyterian Therapeutics | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Arcus Biosciences | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Escient Pharmaceuticals | n/a | n/a | n/a | n/a | Unknown | Sep 16, 2026 |
| Investor | Co-investor | Shared deals | Shared companies | Last observed | Strength |
|---|---|---|---|---|---|
| The Column Group | Springrock Management | 2 | 2 | Sep 16, 2026 | Recurring |
| The Column Group | Decheng Capital LLC | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Avoro Capital Advisors LLC | 1 | 1 | Sep 16, 2026 | One time |
| Navimed Capital Advisors, LLC | The Column Group | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Amoon Ventures Y.SH. Ltd. | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Omega Fund Management, LLC | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | LUX Capital Management, LLC | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | RA Capital Management, LP | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Lifeforce Capital Management, LLC | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | CRV, LLC | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | City Hill Ventures, LLC | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Mtech Capital | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Iaso Ventures Management Firm LLC | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Mission Biocapital | 1 | 1 | Sep 16, 2026 | One time |
| The Column Group | Prospect Management Co. II, LLC | 1 | 1 | Sep 16, 2026 | One time |
Also named here, with no published line of their own (reach them through the firm): Koning Shen (Associate), David V. Goeddel (Partner Emeritus), Robert Tjian (Discovery Partner), Roger Perlmutter (Science Partner), Charles Sawyers (Science Partner), Huda Y. Zoghbi (Science Partner), Peter Svennilson (Founder / Managing Partner), David Liu (Director of Accounting), Nathan Levy (Director of Tax/Finance), Charles Zuker (Science Partner), Helen Hobbs (Science Partner), Michael Fischbach (Science Partner).
Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan